Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea

Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract can...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepato-biliary-pancreatic sciences 2024-07, Vol.31 (7), p.481-491
Hauptverfasser: Yabushita, Yasuhiro, Park, Joon Seong, Yoon, Yoo‐Seok, Ohtsuka, Masayuki, Kwon, Wooil, Choi, Gi Hong, Imamura, Masafumi, Matsumoto, Ippei, Mizuno, Shugo, Matsuyama, Ryusei, Sakata, Jun, Hayashi, Hiromitsu, Takeda, Yutaka, Katagiri, Satoshi, Sugawara, Toshitaka, Kobayashi, Shogo, Kawasaki, Yota, Nagano, Hiroaki, Murase, Katsutoshi, Kim, Hyung Sun, Nah, Yang Won, Jang, Jin‐Young, Yamaue, Hiroki, Yoon, Dong Sup, Yamamoto, Masakazu, Choi, Dongho, Nakamura, Masafumi, Kim, Ki‐Hun, Endo, Itaru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 491
container_issue 7
container_start_page 481
container_title Journal of hepato-biliary-pancreatic sciences
container_volume 31
creator Yabushita, Yasuhiro
Park, Joon Seong
Yoon, Yoo‐Seok
Ohtsuka, Masayuki
Kwon, Wooil
Choi, Gi Hong
Imamura, Masafumi
Matsumoto, Ippei
Mizuno, Shugo
Matsuyama, Ryusei
Sakata, Jun
Hayashi, Hiromitsu
Takeda, Yutaka
Katagiri, Satoshi
Sugawara, Toshitaka
Kobayashi, Shogo
Kawasaki, Yota
Nagano, Hiroaki
Murase, Katsutoshi
Kim, Hyung Sun
Nah, Yang Won
Jang, Jin‐Young
Yamaue, Hiroki
Yoon, Dong Sup
Yamamoto, Masakazu
Choi, Dongho
Nakamura, Masafumi
Kim, Ki‐Hun
Endo, Itaru
description Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract cancer. This study aimed to evaluate the efficacy and safety of conversion surgery in patients with initially unresectable locally advanced biliary tract cancer. Methods We retrospectively collected clinical data from groups of patients in multiple centers belonging to the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and Korean Association of Hepato‐Biliary‐Pancreatic Surgery. We analyzed two groups of prognostic factors (pretreatment and surgical factors) and their relation to the treatment outcomes. Results A total of 56 patients with initially unresectable locally advanced biliary tract cancer were enrolled in this study of which 55 (98.2%) patients received chemotherapy, and 16 (28.6%) patients received additional radiation therapy. The median time from the start of the initial treatment to resection was 6.4 months. Severe postoperative complications of Clavien‐Dindo grade III or higher occurred in 34 patients (60.7%), and postoperative mortality occurred in five patients (8.9%). Postoperative histological results revealed CR in eight patients (14.3%). The median survival time from the start of the initial treatment in all 56 patients who underwent conversion surgery was 37.7 months, the 3‐year survival rate was 53.9%, and the 5‐year survival rate was 39.1%. Conclusions Conversion surgery for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. However, more precise preoperative safety evaluation and careful postoperative management are required. In this multicenter retrospective study conducted at Japanese and Korean hepatobiliary pancreatic centers, Yabushita and colleagues found that conversion surgery performed after preoperative treatment for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. Improved preoperative safety evaluation and postoperative management, however, are warranted.
doi_str_mv 10.1002/jhbp.1437
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3063465793</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3063465793</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2437-abf56e329b0e78aea1bde6ccecde9cf2f90b3992ac982ca0db0160652e9724ec3</originalsourceid><addsrcrecordid>eNp1kc1uEzEUhS0EolXpghdAltjAIq1_JjNjdiUCSqkEC1iPru074Mixg3-C8hy8ME5TukDibmwdfT66PoeQ55xdcMbE5fqH3l7wTg6PyCkf-3HRq1E8frgP3Qk5z3nN2kgulWRPyYkcR9FmOCW_VzHsMGUXA801fce0p3NM1AVXHHi_pzUkzGgKaI_UR3Mngt1BMGipdt5Be1MSmELNQUxv6BXdVF-cwVAwURO9Bx0TFLdDmku1-6YFW01pDi7QG9hCoBAs_RQTwjPyZAaf8fz-PCPf3r_7urpe3H7-8HF1dbswon13AXpe9iiF0gyHERC4ttgbg8aiMrOYFdNSKQGmBWKAWc14z_qlQDWIDo08I6-OvtsUf1bMZdq4bLAtGzDWPEnWy65fDko29OU_6DrWFNp2jRo73i1bmo16faRMijknnKdtcpsWz8TZdChrOpQ1Hcpq7It7x6o3aB_Iv9U04PII_HIe9_93mm6u3365s_wDL2WiBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084145227</pqid></control><display><type>article</type><title>Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yabushita, Yasuhiro ; Park, Joon Seong ; Yoon, Yoo‐Seok ; Ohtsuka, Masayuki ; Kwon, Wooil ; Choi, Gi Hong ; Imamura, Masafumi ; Matsumoto, Ippei ; Mizuno, Shugo ; Matsuyama, Ryusei ; Sakata, Jun ; Hayashi, Hiromitsu ; Takeda, Yutaka ; Katagiri, Satoshi ; Sugawara, Toshitaka ; Kobayashi, Shogo ; Kawasaki, Yota ; Nagano, Hiroaki ; Murase, Katsutoshi ; Kim, Hyung Sun ; Nah, Yang Won ; Jang, Jin‐Young ; Yamaue, Hiroki ; Yoon, Dong Sup ; Yamamoto, Masakazu ; Choi, Dongho ; Nakamura, Masafumi ; Kim, Ki‐Hun ; Endo, Itaru</creator><creatorcontrib>Yabushita, Yasuhiro ; Park, Joon Seong ; Yoon, Yoo‐Seok ; Ohtsuka, Masayuki ; Kwon, Wooil ; Choi, Gi Hong ; Imamura, Masafumi ; Matsumoto, Ippei ; Mizuno, Shugo ; Matsuyama, Ryusei ; Sakata, Jun ; Hayashi, Hiromitsu ; Takeda, Yutaka ; Katagiri, Satoshi ; Sugawara, Toshitaka ; Kobayashi, Shogo ; Kawasaki, Yota ; Nagano, Hiroaki ; Murase, Katsutoshi ; Kim, Hyung Sun ; Nah, Yang Won ; Jang, Jin‐Young ; Yamaue, Hiroki ; Yoon, Dong Sup ; Yamamoto, Masakazu ; Choi, Dongho ; Nakamura, Masafumi ; Kim, Ki‐Hun ; Endo, Itaru</creatorcontrib><description>Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract cancer. This study aimed to evaluate the efficacy and safety of conversion surgery in patients with initially unresectable locally advanced biliary tract cancer. Methods We retrospectively collected clinical data from groups of patients in multiple centers belonging to the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and Korean Association of Hepato‐Biliary‐Pancreatic Surgery. We analyzed two groups of prognostic factors (pretreatment and surgical factors) and their relation to the treatment outcomes. Results A total of 56 patients with initially unresectable locally advanced biliary tract cancer were enrolled in this study of which 55 (98.2%) patients received chemotherapy, and 16 (28.6%) patients received additional radiation therapy. The median time from the start of the initial treatment to resection was 6.4 months. Severe postoperative complications of Clavien‐Dindo grade III or higher occurred in 34 patients (60.7%), and postoperative mortality occurred in five patients (8.9%). Postoperative histological results revealed CR in eight patients (14.3%). The median survival time from the start of the initial treatment in all 56 patients who underwent conversion surgery was 37.7 months, the 3‐year survival rate was 53.9%, and the 5‐year survival rate was 39.1%. Conclusions Conversion surgery for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. However, more precise preoperative safety evaluation and careful postoperative management are required. In this multicenter retrospective study conducted at Japanese and Korean hepatobiliary pancreatic centers, Yabushita and colleagues found that conversion surgery performed after preoperative treatment for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. Improved preoperative safety evaluation and postoperative management, however, are warranted.</description><identifier>ISSN: 1868-6974</identifier><identifier>ISSN: 1868-6982</identifier><identifier>EISSN: 1868-6982</identifier><identifier>DOI: 10.1002/jhbp.1437</identifier><identifier>PMID: 38822227</identifier><language>eng</language><publisher>Japan: Wiley Subscription Services, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; biliary tract cancer ; Biliary Tract Neoplasms - mortality ; Biliary Tract Neoplasms - pathology ; Biliary Tract Neoplasms - surgery ; Biliary Tract Surgical Procedures - methods ; Cancer therapies ; Cholangiocarcinoma ; conversion surgery ; Female ; Humans ; Japan ; locally advanced ; Male ; Medical prognosis ; Middle Aged ; Neoplasm Staging ; Prognosis ; Republic of Korea ; Retrospective Studies ; Surgery ; Survival Rate ; Treatment Outcome ; unresectable</subject><ispartof>Journal of hepato-biliary-pancreatic sciences, 2024-07, Vol.31 (7), p.481-491</ispartof><rights>2024 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery.</rights><rights>Copyright © 2024 Japanese Society of Hepato‐Biliary‐Pancreatic Surgery</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2437-abf56e329b0e78aea1bde6ccecde9cf2f90b3992ac982ca0db0160652e9724ec3</cites><orcidid>0000-0003-1090-1614 ; 0000-0002-1593-3773 ; 0000-0002-2253-544X ; 0000-0001-5520-8114 ; 0000-0003-3965-3693 ; 0000-0002-8828-1067 ; 0000-0001-8048-9990 ; 0000-0001-7621-8557 ; 0000-0002-6982-3457</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjhbp.1437$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjhbp.1437$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38822227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yabushita, Yasuhiro</creatorcontrib><creatorcontrib>Park, Joon Seong</creatorcontrib><creatorcontrib>Yoon, Yoo‐Seok</creatorcontrib><creatorcontrib>Ohtsuka, Masayuki</creatorcontrib><creatorcontrib>Kwon, Wooil</creatorcontrib><creatorcontrib>Choi, Gi Hong</creatorcontrib><creatorcontrib>Imamura, Masafumi</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Mizuno, Shugo</creatorcontrib><creatorcontrib>Matsuyama, Ryusei</creatorcontrib><creatorcontrib>Sakata, Jun</creatorcontrib><creatorcontrib>Hayashi, Hiromitsu</creatorcontrib><creatorcontrib>Takeda, Yutaka</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Sugawara, Toshitaka</creatorcontrib><creatorcontrib>Kobayashi, Shogo</creatorcontrib><creatorcontrib>Kawasaki, Yota</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><creatorcontrib>Murase, Katsutoshi</creatorcontrib><creatorcontrib>Kim, Hyung Sun</creatorcontrib><creatorcontrib>Nah, Yang Won</creatorcontrib><creatorcontrib>Jang, Jin‐Young</creatorcontrib><creatorcontrib>Yamaue, Hiroki</creatorcontrib><creatorcontrib>Yoon, Dong Sup</creatorcontrib><creatorcontrib>Yamamoto, Masakazu</creatorcontrib><creatorcontrib>Choi, Dongho</creatorcontrib><creatorcontrib>Nakamura, Masafumi</creatorcontrib><creatorcontrib>Kim, Ki‐Hun</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><title>Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea</title><title>Journal of hepato-biliary-pancreatic sciences</title><addtitle>J Hepatobiliary Pancreat Sci</addtitle><description>Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract cancer. This study aimed to evaluate the efficacy and safety of conversion surgery in patients with initially unresectable locally advanced biliary tract cancer. Methods We retrospectively collected clinical data from groups of patients in multiple centers belonging to the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and Korean Association of Hepato‐Biliary‐Pancreatic Surgery. We analyzed two groups of prognostic factors (pretreatment and surgical factors) and their relation to the treatment outcomes. Results A total of 56 patients with initially unresectable locally advanced biliary tract cancer were enrolled in this study of which 55 (98.2%) patients received chemotherapy, and 16 (28.6%) patients received additional radiation therapy. The median time from the start of the initial treatment to resection was 6.4 months. Severe postoperative complications of Clavien‐Dindo grade III or higher occurred in 34 patients (60.7%), and postoperative mortality occurred in five patients (8.9%). Postoperative histological results revealed CR in eight patients (14.3%). The median survival time from the start of the initial treatment in all 56 patients who underwent conversion surgery was 37.7 months, the 3‐year survival rate was 53.9%, and the 5‐year survival rate was 39.1%. Conclusions Conversion surgery for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. However, more precise preoperative safety evaluation and careful postoperative management are required. In this multicenter retrospective study conducted at Japanese and Korean hepatobiliary pancreatic centers, Yabushita and colleagues found that conversion surgery performed after preoperative treatment for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. Improved preoperative safety evaluation and postoperative management, however, are warranted.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>biliary tract cancer</subject><subject>Biliary Tract Neoplasms - mortality</subject><subject>Biliary Tract Neoplasms - pathology</subject><subject>Biliary Tract Neoplasms - surgery</subject><subject>Biliary Tract Surgical Procedures - methods</subject><subject>Cancer therapies</subject><subject>Cholangiocarcinoma</subject><subject>conversion surgery</subject><subject>Female</subject><subject>Humans</subject><subject>Japan</subject><subject>locally advanced</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Republic of Korea</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><subject>unresectable</subject><issn>1868-6974</issn><issn>1868-6982</issn><issn>1868-6982</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1uEzEUhS0EolXpghdAltjAIq1_JjNjdiUCSqkEC1iPru074Mixg3-C8hy8ME5TukDibmwdfT66PoeQ55xdcMbE5fqH3l7wTg6PyCkf-3HRq1E8frgP3Qk5z3nN2kgulWRPyYkcR9FmOCW_VzHsMGUXA801fce0p3NM1AVXHHi_pzUkzGgKaI_UR3Mngt1BMGipdt5Be1MSmELNQUxv6BXdVF-cwVAwURO9Bx0TFLdDmku1-6YFW01pDi7QG9hCoBAs_RQTwjPyZAaf8fz-PCPf3r_7urpe3H7-8HF1dbswon13AXpe9iiF0gyHERC4ttgbg8aiMrOYFdNSKQGmBWKAWc14z_qlQDWIDo08I6-OvtsUf1bMZdq4bLAtGzDWPEnWy65fDko29OU_6DrWFNp2jRo73i1bmo16faRMijknnKdtcpsWz8TZdChrOpQ1Hcpq7It7x6o3aB_Iv9U04PII_HIe9_93mm6u3365s_wDL2WiBA</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Yabushita, Yasuhiro</creator><creator>Park, Joon Seong</creator><creator>Yoon, Yoo‐Seok</creator><creator>Ohtsuka, Masayuki</creator><creator>Kwon, Wooil</creator><creator>Choi, Gi Hong</creator><creator>Imamura, Masafumi</creator><creator>Matsumoto, Ippei</creator><creator>Mizuno, Shugo</creator><creator>Matsuyama, Ryusei</creator><creator>Sakata, Jun</creator><creator>Hayashi, Hiromitsu</creator><creator>Takeda, Yutaka</creator><creator>Katagiri, Satoshi</creator><creator>Sugawara, Toshitaka</creator><creator>Kobayashi, Shogo</creator><creator>Kawasaki, Yota</creator><creator>Nagano, Hiroaki</creator><creator>Murase, Katsutoshi</creator><creator>Kim, Hyung Sun</creator><creator>Nah, Yang Won</creator><creator>Jang, Jin‐Young</creator><creator>Yamaue, Hiroki</creator><creator>Yoon, Dong Sup</creator><creator>Yamamoto, Masakazu</creator><creator>Choi, Dongho</creator><creator>Nakamura, Masafumi</creator><creator>Kim, Ki‐Hun</creator><creator>Endo, Itaru</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1090-1614</orcidid><orcidid>https://orcid.org/0000-0002-1593-3773</orcidid><orcidid>https://orcid.org/0000-0002-2253-544X</orcidid><orcidid>https://orcid.org/0000-0001-5520-8114</orcidid><orcidid>https://orcid.org/0000-0003-3965-3693</orcidid><orcidid>https://orcid.org/0000-0002-8828-1067</orcidid><orcidid>https://orcid.org/0000-0001-8048-9990</orcidid><orcidid>https://orcid.org/0000-0001-7621-8557</orcidid><orcidid>https://orcid.org/0000-0002-6982-3457</orcidid></search><sort><creationdate>202407</creationdate><title>Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea</title><author>Yabushita, Yasuhiro ; Park, Joon Seong ; Yoon, Yoo‐Seok ; Ohtsuka, Masayuki ; Kwon, Wooil ; Choi, Gi Hong ; Imamura, Masafumi ; Matsumoto, Ippei ; Mizuno, Shugo ; Matsuyama, Ryusei ; Sakata, Jun ; Hayashi, Hiromitsu ; Takeda, Yutaka ; Katagiri, Satoshi ; Sugawara, Toshitaka ; Kobayashi, Shogo ; Kawasaki, Yota ; Nagano, Hiroaki ; Murase, Katsutoshi ; Kim, Hyung Sun ; Nah, Yang Won ; Jang, Jin‐Young ; Yamaue, Hiroki ; Yoon, Dong Sup ; Yamamoto, Masakazu ; Choi, Dongho ; Nakamura, Masafumi ; Kim, Ki‐Hun ; Endo, Itaru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2437-abf56e329b0e78aea1bde6ccecde9cf2f90b3992ac982ca0db0160652e9724ec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>biliary tract cancer</topic><topic>Biliary Tract Neoplasms - mortality</topic><topic>Biliary Tract Neoplasms - pathology</topic><topic>Biliary Tract Neoplasms - surgery</topic><topic>Biliary Tract Surgical Procedures - methods</topic><topic>Cancer therapies</topic><topic>Cholangiocarcinoma</topic><topic>conversion surgery</topic><topic>Female</topic><topic>Humans</topic><topic>Japan</topic><topic>locally advanced</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Republic of Korea</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><topic>unresectable</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yabushita, Yasuhiro</creatorcontrib><creatorcontrib>Park, Joon Seong</creatorcontrib><creatorcontrib>Yoon, Yoo‐Seok</creatorcontrib><creatorcontrib>Ohtsuka, Masayuki</creatorcontrib><creatorcontrib>Kwon, Wooil</creatorcontrib><creatorcontrib>Choi, Gi Hong</creatorcontrib><creatorcontrib>Imamura, Masafumi</creatorcontrib><creatorcontrib>Matsumoto, Ippei</creatorcontrib><creatorcontrib>Mizuno, Shugo</creatorcontrib><creatorcontrib>Matsuyama, Ryusei</creatorcontrib><creatorcontrib>Sakata, Jun</creatorcontrib><creatorcontrib>Hayashi, Hiromitsu</creatorcontrib><creatorcontrib>Takeda, Yutaka</creatorcontrib><creatorcontrib>Katagiri, Satoshi</creatorcontrib><creatorcontrib>Sugawara, Toshitaka</creatorcontrib><creatorcontrib>Kobayashi, Shogo</creatorcontrib><creatorcontrib>Kawasaki, Yota</creatorcontrib><creatorcontrib>Nagano, Hiroaki</creatorcontrib><creatorcontrib>Murase, Katsutoshi</creatorcontrib><creatorcontrib>Kim, Hyung Sun</creatorcontrib><creatorcontrib>Nah, Yang Won</creatorcontrib><creatorcontrib>Jang, Jin‐Young</creatorcontrib><creatorcontrib>Yamaue, Hiroki</creatorcontrib><creatorcontrib>Yoon, Dong Sup</creatorcontrib><creatorcontrib>Yamamoto, Masakazu</creatorcontrib><creatorcontrib>Choi, Dongho</creatorcontrib><creatorcontrib>Nakamura, Masafumi</creatorcontrib><creatorcontrib>Kim, Ki‐Hun</creatorcontrib><creatorcontrib>Endo, Itaru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yabushita, Yasuhiro</au><au>Park, Joon Seong</au><au>Yoon, Yoo‐Seok</au><au>Ohtsuka, Masayuki</au><au>Kwon, Wooil</au><au>Choi, Gi Hong</au><au>Imamura, Masafumi</au><au>Matsumoto, Ippei</au><au>Mizuno, Shugo</au><au>Matsuyama, Ryusei</au><au>Sakata, Jun</au><au>Hayashi, Hiromitsu</au><au>Takeda, Yutaka</au><au>Katagiri, Satoshi</au><au>Sugawara, Toshitaka</au><au>Kobayashi, Shogo</au><au>Kawasaki, Yota</au><au>Nagano, Hiroaki</au><au>Murase, Katsutoshi</au><au>Kim, Hyung Sun</au><au>Nah, Yang Won</au><au>Jang, Jin‐Young</au><au>Yamaue, Hiroki</au><au>Yoon, Dong Sup</au><au>Yamamoto, Masakazu</au><au>Choi, Dongho</au><au>Nakamura, Masafumi</au><au>Kim, Ki‐Hun</au><au>Endo, Itaru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea</atitle><jtitle>Journal of hepato-biliary-pancreatic sciences</jtitle><addtitle>J Hepatobiliary Pancreat Sci</addtitle><date>2024-07</date><risdate>2024</risdate><volume>31</volume><issue>7</issue><spage>481</spage><epage>491</epage><pages>481-491</pages><issn>1868-6974</issn><issn>1868-6982</issn><eissn>1868-6982</eissn><abstract>Background Although surgical resection is the only curative treatment for biliary tract cancer, in some cases, the disease is diagnosed as unresectable at initial presentation. There are few reports of conversion surgery after the initial treatment for unresectable locally advanced biliary tract cancer. This study aimed to evaluate the efficacy and safety of conversion surgery in patients with initially unresectable locally advanced biliary tract cancer. Methods We retrospectively collected clinical data from groups of patients in multiple centers belonging to the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and Korean Association of Hepato‐Biliary‐Pancreatic Surgery. We analyzed two groups of prognostic factors (pretreatment and surgical factors) and their relation to the treatment outcomes. Results A total of 56 patients with initially unresectable locally advanced biliary tract cancer were enrolled in this study of which 55 (98.2%) patients received chemotherapy, and 16 (28.6%) patients received additional radiation therapy. The median time from the start of the initial treatment to resection was 6.4 months. Severe postoperative complications of Clavien‐Dindo grade III or higher occurred in 34 patients (60.7%), and postoperative mortality occurred in five patients (8.9%). Postoperative histological results revealed CR in eight patients (14.3%). The median survival time from the start of the initial treatment in all 56 patients who underwent conversion surgery was 37.7 months, the 3‐year survival rate was 53.9%, and the 5‐year survival rate was 39.1%. Conclusions Conversion surgery for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. However, more precise preoperative safety evaluation and careful postoperative management are required. In this multicenter retrospective study conducted at Japanese and Korean hepatobiliary pancreatic centers, Yabushita and colleagues found that conversion surgery performed after preoperative treatment for initially unresectable locally advanced biliary tract cancer may lead to longer survival in selected patients. Improved preoperative safety evaluation and postoperative management, however, are warranted.</abstract><cop>Japan</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38822227</pmid><doi>10.1002/jhbp.1437</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0003-1090-1614</orcidid><orcidid>https://orcid.org/0000-0002-1593-3773</orcidid><orcidid>https://orcid.org/0000-0002-2253-544X</orcidid><orcidid>https://orcid.org/0000-0001-5520-8114</orcidid><orcidid>https://orcid.org/0000-0003-3965-3693</orcidid><orcidid>https://orcid.org/0000-0002-8828-1067</orcidid><orcidid>https://orcid.org/0000-0001-8048-9990</orcidid><orcidid>https://orcid.org/0000-0001-7621-8557</orcidid><orcidid>https://orcid.org/0000-0002-6982-3457</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1868-6974
ispartof Journal of hepato-biliary-pancreatic sciences, 2024-07, Vol.31 (7), p.481-491
issn 1868-6974
1868-6982
1868-6982
language eng
recordid cdi_proquest_miscellaneous_3063465793
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Aged
Aged, 80 and over
biliary tract cancer
Biliary Tract Neoplasms - mortality
Biliary Tract Neoplasms - pathology
Biliary Tract Neoplasms - surgery
Biliary Tract Surgical Procedures - methods
Cancer therapies
Cholangiocarcinoma
conversion surgery
Female
Humans
Japan
locally advanced
Male
Medical prognosis
Middle Aged
Neoplasm Staging
Prognosis
Republic of Korea
Retrospective Studies
Surgery
Survival Rate
Treatment Outcome
unresectable
title Conversion surgery for initially unresectable locally advanced biliary tract cancer: A multicenter collaborative study conducted in Japan and Korea
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A58%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conversion%20surgery%20for%20initially%20unresectable%20locally%20advanced%20biliary%20tract%20cancer:%20A%20multicenter%20collaborative%20study%20conducted%20in%20Japan%20and%20Korea&rft.jtitle=Journal%20of%20hepato-biliary-pancreatic%20sciences&rft.au=Yabushita,%20Yasuhiro&rft.date=2024-07&rft.volume=31&rft.issue=7&rft.spage=481&rft.epage=491&rft.pages=481-491&rft.issn=1868-6974&rft.eissn=1868-6982&rft_id=info:doi/10.1002/jhbp.1437&rft_dat=%3Cproquest_cross%3E3063465793%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3084145227&rft_id=info:pmid/38822227&rfr_iscdi=true